Last Updated: November 8, 2026

Patent: 10,307,551

Summary for Patent: 10,307,551

Title:	Controlled inhaler for distributing inhalant according to inhalation velocity
Abstract:	An inhaler is provided that includes a controller, a driver, an atomizer and one or more sensors for detecting information about a velocity of inhalation of a user of the inhaler. The controller is configured to dispense an inhalant from the inhaler during an inhalation of the user based on information about the velocity of inhalation of the user. Such information can include a duration of maximum inhalation velocity or an increase or maximum in the acceleration in inhalation velocity. Embodiments of the inhaler can be used to enhance the delivery of drugs and therapeutic agents for those patients having a weakened respiratory system who are unable to take a deep or full breadth, e.g., patients having asthma or COPD. Embodiments of the inhaler can be used to deliver a variety of drugs and therapeutic agents including agents for the treatment of asthma, diabetes, epilepsy and heart disease.
Inventor(s):	Imran; Mir (Los Altos Hills, CA)
Assignee:	InCube Labs, LLC (San Jose, CA)
Application Number:	15/263,768
Patent Claims:	see list of patent claims

Details for Patent 10,307,551

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Eli Lilly And Company	HUMULIN R U-100	insulin human	Injection	018780	October 28, 1982	⤷ Start Trial	2036-09-13
Eli Lilly And Company	HUMULIN R U-500	insulin human	Injection	018780	December 29, 2015	⤷ Start Trial	2036-09-13
Eli Lilly And Company	HUMULIN R U-100	insulin human	Injection	018780	August 6, 1998	⤷ Start Trial	2036-09-13
Eli Lilly And Company	HUMULIN R U-500	insulin human	Injection	018780	March 31, 1994	⤷ Start Trial	2036-09-13
Eli Lilly And Company	HUMULIN R U-100	insulin human	Injection	018780	May 25, 2018	⤷ Start Trial	2036-09-13
Novo Nordisk Inc.	NOVOLIN R	insulin human	Injection	019938	June 25, 1991	⤷ Start Trial	2036-09-13
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.